BlueRock Therapeutics is a clinical stage biotechnology company focused on developing innovative cell therapies for individuals with neurological and ophthalmic diseases. We're creating a pipeline of transformative medicines, including therapies for Parkinson's disease and primary photoreceptor diseases, leveraging the latest advancements in cell therapy to directly address critical health challenges.
